Advertisement

Journal of Endocrinological Investigation

, Volume 39, Issue 9, pp 1003–1013 | Cite as

Radiofrequency ablation for benign thyroid nodules

  • S. BernardiEmail author
  • F. Stacul
  • M. Zecchin
  • C. Dobrinja
  • F. Zanconati
  • B. Fabris
Short Review

Abstract

Benign thyroid nodules are an extremely common occurrence. Radiofrequency ablation (RFA) is gaining ground as an effective technique for their treatment, in case they become symptomatic. Here we review what are the current indications to RFA, its outcomes in terms of efficacy, tolerability, and cost, and also how it compares to the other conventional and experimental treatment modalities for benign thyroid nodules. Moreover, we will also address the issue of treating with this technique patients with cardiac pacemakers (PM) or implantable cardioverter-defibrillators (ICD), as it is a rather frequent occurrence that has never been addressed in detail in the literature.

Keywords

Radiofrequency ablation Thyroid nodule Pacemaker Implantable cardioverter-defbrillator Ultrasound-guided procedure Minimally invasive nonsurgical techniques 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study formal consent is not required.

References

  1. 1.
    Gnarini VL, Brigante G, Della Valle E, Diazzi C, Madeo B, Carani C, Rochira V, Simoni M (2013) Very high prevalence of ultrasound thyroid scan abnormalities in healthy volunteers in Modena, Italy. J Endocrinol Invest 36:722–728PubMedGoogle Scholar
  2. 2.
    Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG (2011) Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol 12:525–540CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Wong KP, Lang BH (2013) Use of radiofrequency ablation in benign thyroid nodules: a literature review and updates. Int J Endocrinol 2013:428363CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Gharib H, Hegedus L, Pacella CM, Baek JH, Papini E (2013) Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab 98:3949–3957CrossRefPubMedGoogle Scholar
  5. 5.
    Papini E, Pacella CM, Hegedus L (2014) Diagnosis of endocrine disease: thyroid ultrasound (US) and US-assisted procedures: from the shadows into an array of applications. Eur J Endocrinol 170:R133–R146CrossRefPubMedGoogle Scholar
  6. 6.
    Lupo MA (2015) Radiofrequency ablation for benign thyroid nodules—a look towards the future of interventional thyroidology. Endocr Pract 21:972–974CrossRefPubMedGoogle Scholar
  7. 7.
    Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, Gilbert J, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V, Newbold K, Taylor J, Thakker RV, Watkinson J, Williams GR, British Thyroid A (2014) Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 81(Suppl 1):1–122CrossRefGoogle Scholar
  8. 8.
    Haugen BRM, Alexander EK, Bible KC, Doherty G, Mandel SJ, Nikiforov YE, Pacini F, Randolph G, Sawka A, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward D, Tuttle RMM, Wartofsky L (2015) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133Google Scholar
  9. 9.
    Zhao Q, Tian G, Kong D, Jiang T (2016) Meta-analysis of radiofrequency ablation for treating the local recurrence of thyroid cancers. J Endocrinol Invest. doi: 10.1007/s40618-016-0450-8
  10. 10.
    Garberoglio R, Aliberti C, Appetecchia M, Attard M, Boccuzzi G, Boraso F, Borretta G, Caruso G, Deandrea M, Freddi M, Gallone G, Gandini G, Gasparri G, Gazzera C, Ghigo E, Grosso M, Limone P, Maccario M, Mansi L, Mormile A, Nasi PG, Orlandi F, Pacchioni D, Pacella CM, Palestini N, Papini E, Pelizzo MR, Piotto A, Rago T, Riganti F, Rosato L, Rossetto R, Scarmozzino A, Spiezia S, Testori O, Valcavi R, Veltri A, Vitti P, Zingrillo M (2015) Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement. J Ultrasound 18:423–430CrossRefPubMedGoogle Scholar
  11. 11.
    Bernardi S, Dobrinja C, Fabris B, Bazzocchi G, Sabato N, Ulcigrai V, Giacca M, Barro E, De Manzini N, Stacul F (2014) Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules. Int J Endocrinol 2014:934595CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Dobrinja C, Bernardi S, Fabris B, Eramo R, Makovac P, Bazzocchi G, Piscopello L, Barro E, de Manzini N, Bonazza D, Pinamonti M, Zanconati F, Stacul F (2015) Surgical and Pathological changes after radiofrequency ablation of thyroid nodules. Int J Endocrinol 2015:576576CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Bernardi S, Lanzilotti V, Papa G, Panizzo N, Dobrinja C, Fabris B, Stacul F (2015) Full-thickness skin burn caused by radiofrequency ablation of a benign thyroid nodule. Thyroid 26:183–184CrossRefPubMedGoogle Scholar
  14. 14.
    Kim YS, Rhim H, Tae K, Park DW, Kim ST (2006) Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid 16:361–367CrossRefPubMedGoogle Scholar
  15. 15.
    Spiezia S, Garberoglio R, Di Somma C, Deandrea M, Basso E, Limone PP, Milone F, Ramundo V, Macchia PE, Biondi B, Lombardi G, Colao A, Faggiano A (2007) Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. J Am Geriatr Soc 55:1478–1479CrossRefPubMedGoogle Scholar
  16. 16.
    Deandrea M, Limone P, Basso E, Mormile A, Ragazzoni F, Gamarra E, Spiezia S, Faggiano A, Colao A, Molinari F, Garberoglio R (2008) US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol 34:784–791CrossRefPubMedGoogle Scholar
  17. 17.
    Jeong WK, Baek JH, Rhim H, Kim YS, Kwak MS, Jeong HJ, Lee D (2008) Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18:1244–1250CrossRefPubMedGoogle Scholar
  18. 18.
    Spiezia S, Garberoglio R, Milone F, Ramundo V, Caiazzo C, Assanti AP, Deandrea M, Limone PP, Macchia PE, Lombardi G, Colao A, Faggiano A (2009) Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 19:219–225CrossRefPubMedGoogle Scholar
  19. 19.
    Baek JH, Kim YS, Lee D, Huh JY, Lee JH (2010) Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol 194:1137–1142CrossRefPubMedGoogle Scholar
  20. 20.
    Na DG, Lee JH, Jung SL, Kim JH, Sung JY, Shin JH, Kim EK, Lee JH, Kim DW, Park JS, Kim KS, Baek SM, Lee Y, Chong S, Sim JS, Huh JY, Bae JI, Kim KT, Han SY, Bae MY, Kim YS, Baek JH, Korean Society of Thyroid R, Korean Society of R (2012) Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol 13:117–125CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Burman KD, Wartofsky L (2015) Clinical practice. Thyroid nodules. N Engl J Med 373:2347–2356CrossRefPubMedGoogle Scholar
  22. 22.
    Nardi F, Basolo F, Crescenzi A, Fadda G, Frasoldati A, Orlandi F, Palombini L, Papini E, Zini M, Pontecorvi A, Vitti P (2014) Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Invest 37:593–599CrossRefPubMedGoogle Scholar
  23. 23.
    Cibas ES, Ali SZ, Conference NCITFSotS (2009) The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132:658–665CrossRefPubMedGoogle Scholar
  24. 24.
    Wang CC, Friedman L, Kennedy GC, Wang H, Kebebew E, Steward DL, Zeiger MA, Westra WH, Wang Y, Khanafshar E, Fellegara G, Rosai J, Livolsi V, Lanman RB (2011) A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid 21:243–251CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Kim HY, Ryu WS, Woo SU, Son GS, Lee ES, Lee JB, Bae JW (2010) Primary papillary thyroid carcinoma previously treated incompletely with radiofrequency ablation. J Cancer Res Ther 6:310–312CrossRefPubMedGoogle Scholar
  26. 26.
    Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW (2007) ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 50:1707–1732CrossRefPubMedGoogle Scholar
  27. 27.
    American Society of Anesthesiologists Task Force on perioperative management of patients with cardiac rhythm management D (2005) Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on perioperative management of patients with cardiac rhythm management devices. Anesthesiology 103:186–198CrossRefGoogle Scholar
  28. 28.
    Tong NY, Ru HJ, Ling HY, Cheung YC, Meng LW, Chung PC (2004) Extracardiac radiofrequency ablation interferes with pacemaker function but does not damage the device. Anesthesiology 100:1041CrossRefPubMedGoogle Scholar
  29. 29.
    Pfeiffer D, Tebbenjohanns J, Schumacher B, Jung W, Luderitz B (1995) Pacemaker function during radiofrequency ablation. Pacing Clin Electrophysiol 18:1037–1044CrossRefPubMedGoogle Scholar
  30. 30.
    Hayes DL, Charboneau JW, Lewis BD, Asirvatham SJ, Dupuy DE, Lexvold NY (2001) Radiofrequency treatment of hepatic neoplasms in patients with permanent pacemakers. Mayo Clin Proc 76:950–952CrossRefPubMedGoogle Scholar
  31. 31.
    Crossley GH, Poole JE, Rozner MA, Asirvatham SJ, Cheng A, Chung MK, Ferguson TB Jr, Gallagher JD, Gold MR, Hoyt RH, Irefin S, Kusumoto FM, Moorman LP, Thompson A (2011) The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) expert consensus statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm 8:1114–1154CrossRefPubMedGoogle Scholar
  32. 32.
    Faggiano A, Ramundo V, Assanti AP, Fonderico F, Macchia PE, Misso C, Marciello F, Marotta V, Del Prete M, Papini E, Lombardi G, Colao A, Spiezia S (2012) Thyroid nodules treated with percutaneous radiofrequency thermal ablation: a comparative study. J Clin Endocrinol Metab 97:4439–4445CrossRefPubMedGoogle Scholar
  33. 33.
    Deandrea M, Sung JY, Limone P, Mormile A, Garino F, Ragazzoni F, Kim KS, Lee D, Baek JH (2015) Efficacy and safety of radiofrequency ablation versus observation for nonfunctioning benign thyroid nodules: a randomized controlled international collaborative trial. Thyroid 25:890–896CrossRefPubMedGoogle Scholar
  34. 34.
    Valcavi R, Tsamatropoulos P (2015) Health-related quality of life after percutaneous radiofrequency ablation of cold, solid, benign thyroid nodules: a 2-Year follow-up study in 40 patients. Endocr Pract 21:887–896CrossRefPubMedGoogle Scholar
  35. 35.
    Lim HK, Lee JH, Ha EJ, Sung JY, Kim JK, Baek JH (2013) Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients. Eur Radiol 23:1044–1049CrossRefPubMedGoogle Scholar
  36. 36.
    Lee JH, Kim YS, Lee D, Choi H, Yoo H, Baek JH (2010) Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J Surg 34:1488–1493CrossRefPubMedGoogle Scholar
  37. 37.
    Sung JY, Kim YS, Choi H, Lee JH, Baek JH (2011) Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? AJR Am J Roentgenol 196:W210–W214CrossRefPubMedGoogle Scholar
  38. 38.
    Sung JY, Baek JH, Kim KS, Lee D, Yoo H, Kim JK, Park SH (2013) Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: a prospective randomized study. Radiology 269:293–300CrossRefPubMedGoogle Scholar
  39. 39.
    Baek JH, Moon WJ, Kim YS, Lee JH, Lee D (2009) Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg 33:1971–1977CrossRefPubMedGoogle Scholar
  40. 40.
    Huh JY, Baek JH, Choi H, Kim JK, Lee JH (2012) Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session—prospective randomized study. Radiology 263:909–916CrossRefPubMedGoogle Scholar
  41. 41.
    Baek JH, Lee JH, Sung JY, Bae JI, Kim KT, Sim J, Baek SM, Kim YS, Shin JH, Park JS, Kim DW, Kim JH, Kim EK, Jung SL, Na DG, Korean Society of Thyroid R (2012) Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology 262:335–342CrossRefPubMedGoogle Scholar
  42. 42.
    Shin JH, Jung SL, Baek JH, Kim JH (2011) Rupture of benign thyroid tumors after radio-frequency ablation. AJNR Am J Neuroradiol 32:2165–2169CrossRefPubMedGoogle Scholar
  43. 43.
    Kobayashi A, Kuma K, Matsuzuka F, Hirai K, Fukata S, Sugawara M (1992) Thyrotoxicosis after needle aspiration of thyroid cyst. J Clin Endocrinol Metab 75:21–24PubMedGoogle Scholar
  44. 44.
    Che Y, Jin S, Shi C, Wang L, Zhang X, Li Y, Baek JH (2015) Treatment of Benign thyroid nodules: comparison of surgery with radiofrequency ablation. AJNR Am J Neuroradiol 36:1321–1325CrossRefPubMedGoogle Scholar
  45. 45.
    Ferrari C, Reschini E, Paracchi A (1996) Treatment of the autonomous thyroid nodule: a review. Eur J Endocrinol 135:383–390CrossRefPubMedGoogle Scholar
  46. 46.
    Nygaard B, Hegedus L, Nielsen KG, Ulriksen P, Hansen JM (1999) Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf) 50:197–202CrossRefGoogle Scholar
  47. 47.
    Ceccarelli C, Bencivelli W, Vitti P, Grasso L, Pinchera A (2005) Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study. Clin Endocrinol (Oxf) 62:331–335CrossRefGoogle Scholar
  48. 48.
    Hegedus L (2004) Clinical practice. The thyroid nodule. N Engl J Med 351:1764–1771CrossRefPubMedGoogle Scholar
  49. 49.
    Chianelli M, Bizzarri G, Todino V, Misischi I, Bianchini A, Graziano F, Guglielmi R, Pacella CM, Gharib H, Papini E (2014) Laser ablation and 131-iodine: a 24-month pilot study of combined treatment for large toxic nodular goiter. J Clin Endocrinol Metab 99:E1283–E1286CrossRefPubMedGoogle Scholar
  50. 50.
    Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME, Duick DS, Guglielmi R, Hamilton CR Jr, Zeiger MA, Zini M, Nodules AATFoT (2006) American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63–102CrossRefPubMedGoogle Scholar
  51. 51.
    La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A (1995) Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 122:1–8CrossRefPubMedGoogle Scholar
  52. 52.
    Zelmanovitz F, Genro S, Gross JL (1998) Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 83:3881–3885PubMedGoogle Scholar
  53. 53.
    Wemeau JL, Caron P, Schvartz C, Schlienger JL, Orgiazzi J, Cousty C, Vlaeminck-Guillem V (2002) Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 87:4928–4934CrossRefPubMedGoogle Scholar
  54. 54.
    Castro MR, Caraballo PJ, Morris JC (2002) Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 87:4154–4159CrossRefPubMedGoogle Scholar
  55. 55.
    Puzziello A, Carrano M, Angrisani E, Marotta V, Faggiano A, Zeppa P, Vitale M (2014) Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy. J Endocrinol Invest 37:1181–1186CrossRefPubMedGoogle Scholar
  56. 56.
    Knobel M (2016) Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters. J Endocrinol Invest 39:357–373CrossRefPubMedGoogle Scholar
  57. 57.
    Bandeira-Echtler E, Bergerhoff K, Richter B (2014) Levothyroxine or minimally invasive therapies for benign thyroid nodules. Cochrane Database Syst Rev 6:CD004098PubMedGoogle Scholar
  58. 58.
    Rozman B, Bence-Zigman Z, Tomic-Brzac H, Skreb F, Pavlinovic Z, Simonovic I (1989) Slerosation of thyroid cysts by ethanol. Period Biol 91:1116–1118Google Scholar
  59. 59.
    Baskin HJ, Duic DS, Levine RA (2013) Thyroid ultrasound and ultrasound-guided FNA, 3rd edn. Springer, BerlinCrossRefGoogle Scholar
  60. 60.
    Ha EJ, Baek JH, Kim KW, Pyo J, Lee JH, Baek SH, Dossing H, Hegedus L (2015) Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab 100:1903–1911CrossRefPubMedGoogle Scholar
  61. 61.
    Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM (2010) Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid 20:1253–1261CrossRefPubMedGoogle Scholar
  62. 62.
    Jang SW, Baek JH, Kim JK, Sung JY, Choi H, Lim HK, Park JW, Lee HY, Park S, Lee JH (2012) How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules: role of radiofrequency ablation. Eur J Radiol 81:905–910CrossRefPubMedGoogle Scholar
  63. 63.
    Ha EJ, Baek JH, Lee JH, Sung JY, Lee D, Kim JK, Shong YK (2013) Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy. Thyroid 23:289–293CrossRefPubMedGoogle Scholar
  64. 64.
    Sung JY, Baek JH, Jung SL, Kim J, Kim KS, Lee D, Kim WB, Na DG (2015) Radiofrequency ablation for autonomously functioning thyroid nodules: a multicenter study. Thyroid 25:112–117CrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2016

Authors and Affiliations

  • S. Bernardi
    • 1
    • 2
    Email author
  • F. Stacul
    • 3
  • M. Zecchin
    • 4
  • C. Dobrinja
    • 5
  • F. Zanconati
    • 1
    • 6
  • B. Fabris
    • 1
    • 2
  1. 1.Department of Medical, Surgical and Health SciencesUniversity of Trieste, Medicina Clinica, Cattinara Teaching HospitalTriesteItaly
  2. 2.SS Endocrinologia (UCO Medicina Clinica)Azienda Ospedaliero-Universitaria di Trieste, Cattinara Teaching HospitalTriesteItaly
  3. 3.SC RadiologiaAzienda Ospedaliero-Universitaria di Trieste, Maggiore Hospital, Piazza dell’OspitaleTriesteItaly
  4. 4.UCO Cardiologia, Azienda Ospedaliero-Universitaria di Trieste, Cattinara Teaching HospitalTriesteItaly
  5. 5.UCO Chirurgia Generale, Azienda Ospedaliero-Universitaria di Trieste, Cattinara Teaching HospitalTriesteItaly
  6. 6.UCO Anatomia e Istologia Patologica, Azienda Ospedaliero-Universitaria di Trieste, Cattinara Teaching HospitalTriesteItaly

Personalised recommendations